CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
EnPlusOne Biosciences
start up
United States
- Watertown, Massachusetts
- 21/02/2025
- Unknown
- $10,000,000
EnPlusOne is on a mission to bring RNA and RNA solutions to the world. Its ezRNA™ synthesis platform is a stepwise innovation that can incorporate a diverse array of nucleotide modifications and promises a manufacturing process that can sustainably deliver therapeutic RNA at commercial scales. In addition to direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a vast array of RNA solution applications. For more information, please visit www.enplusonebio.com
- Industry Biotechnology Research
- Website https://www.enplusonebio.com/
- LinkedIn https://www.linkedin.com/company/enplusone-bio/
Related People
Daniel AhlstedtCo Founder
United States -
Boston, Massachusetts
Experienced biotechnology process engineer with a demonstrated history of supporting manufacturing operations, equipment design, and start-up of large capital projects while adhering to FDA and international regulations.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)